A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions

Sho Mizukawa; Hironari Kato; Shinichiro Muro; Yutaka Akimoto; Daisuke Uchida; Takeshi Tomoda; Kazuyuki Matsumoto; Naoki Yamamoto; Shigeru Horiguchi; Koichiro Tsutsumi; Hiroyuki Okada; Hirofumi Inoue; Noriyuki Tanaka

A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions

Sho Mizukawa, Hironari Kato, Shinichiro Muro, Yutaka Akimoto, Daisuke Uchida, Takeshi Tomoda, Kazuyuki Matsumoto, Naoki Yamamoto, Shigeru Horiguchi, Koichiro Tsutsumi, Hiroyuki Okada, Hirofumi Inoue, Noriyuki Tanaka

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a standard procedure for precise histological diagnosis of pancreas tumors, but it is sometimes difficult to obtain adequate specimens. EUS Sonopsy CY® is a newly designed needle with original features. This randomized study will compare the tissue collection rate of EUS Sonopsy CY® to that of a conventional needle in EUS-FNA. The major eligibility criteria are as follows: Patients with a pancreatic mass referred for EUSFNA; age ≥20 years, and performance status < 4. The primary outcome is the tissue collection rate. This study will elucidate the efficacy of EUS Sonopsy CY®.

Original language	English
Pages (from-to)	417-420
Number of pages	4
Journal	Acta medica Okayama
Volume	70
Issue number	5
Publication status	Published - 2016

Keywords

Endoscopic ultrasound-guided fine needle aspiration
Menghini type needle tip
Pancreatic cancer

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Mizukawa, S., Kato, H., Muro, S., Akimoto, Y., Uchida, D., Tomoda, T., Matsumoto, K., Yamamoto, N., Horiguchi, S., Tsutsumi, K., Okada, H., Inoue, H., & Tanaka, N. (2016). A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions. Acta medica Okayama, 70(5), 417-420.

A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions. / Mizukawa, Sho; Kato, Hironari; Muro, Shinichiro et al.

In: Acta medica Okayama, Vol. 70, No. 5, 2016, p. 417-420.

Research output: Contribution to journal › Article › peer-review

Mizukawa, S, Kato, H, Muro, S, Akimoto, Y, Uchida, D, Tomoda, T, Matsumoto, K, Yamamoto, N, Horiguchi, S , Tsutsumi, K, Okada, H, Inoue, H & Tanaka, N 2016, 'A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions', Acta medica Okayama, vol. 70, no. 5, pp. 417-420.

@article{db8a4ae240da4ccfac913b90e19debf5,

title = "A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions",

abstract = "Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a standard procedure for precise histological diagnosis of pancreas tumors, but it is sometimes difficult to obtain adequate specimens. EUS Sonopsy CY{\textregistered} is a newly designed needle with original features. This randomized study will compare the tissue collection rate of EUS Sonopsy CY{\textregistered} to that of a conventional needle in EUS-FNA. The major eligibility criteria are as follows: Patients with a pancreatic mass referred for EUSFNA; age ≥20 years, and performance status < 4. The primary outcome is the tissue collection rate. This study will elucidate the efficacy of EUS Sonopsy CY{\textregistered}.",

keywords = "Endoscopic ultrasound-guided fine needle aspiration, Menghini type needle tip, Pancreatic cancer",

author = "Sho Mizukawa and Hironari Kato and Shinichiro Muro and Yutaka Akimoto and Daisuke Uchida and Takeshi Tomoda and Kazuyuki Matsumoto and Naoki Yamamoto and Shigeru Horiguchi and Koichiro Tsutsumi and Hiroyuki Okada and Hirofumi Inoue and Noriyuki Tanaka",

note = "Publisher Copyright: {\textcopyright} 2016 by Okayama University Medical School.",

year = "2016",

language = "English",

volume = "70",

pages = "417--420",

journal = "Acta Medica Okayama",

issn = "0386-300X",

publisher = "Okayama University",

number = "5",

}

TY - JOUR

T1 - A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions

AU - Mizukawa, Sho

AU - Kato, Hironari

AU - Muro, Shinichiro

AU - Akimoto, Yutaka

AU - Uchida, Daisuke

AU - Tomoda, Takeshi

AU - Matsumoto, Kazuyuki

AU - Yamamoto, Naoki

AU - Horiguchi, Shigeru

AU - Tsutsumi, Koichiro

AU - Okada, Hiroyuki

AU - Inoue, Hirofumi

AU - Tanaka, Noriyuki

PY - 2016

Y1 - 2016

N2 - Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a standard procedure for precise histological diagnosis of pancreas tumors, but it is sometimes difficult to obtain adequate specimens. EUS Sonopsy CY® is a newly designed needle with original features. This randomized study will compare the tissue collection rate of EUS Sonopsy CY® to that of a conventional needle in EUS-FNA. The major eligibility criteria are as follows: Patients with a pancreatic mass referred for EUSFNA; age ≥20 years, and performance status < 4. The primary outcome is the tissue collection rate. This study will elucidate the efficacy of EUS Sonopsy CY®.

AB - Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a standard procedure for precise histological diagnosis of pancreas tumors, but it is sometimes difficult to obtain adequate specimens. EUS Sonopsy CY® is a newly designed needle with original features. This randomized study will compare the tissue collection rate of EUS Sonopsy CY® to that of a conventional needle in EUS-FNA. The major eligibility criteria are as follows: Patients with a pancreatic mass referred for EUSFNA; age ≥20 years, and performance status < 4. The primary outcome is the tissue collection rate. This study will elucidate the efficacy of EUS Sonopsy CY®.

KW - Endoscopic ultrasound-guided fine needle aspiration

KW - Menghini type needle tip

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84997610562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997610562&partnerID=8YFLogxK

M3 - Article

C2 - 27777439

AN - SCOPUS:84997610562

SN - 0386-300X

VL - 70

SP - 417

EP - 420

JO - Acta Medica Okayama

JF - Acta Medica Okayama

IS - 5

ER -

A prospective randomized controlled study comparing EUS Sonopsy CY(R) and 22-gauge biopsy needles for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this